Alok Tayi

Boris Dyakov, a PhD candidate at the University of Toronto, Mikey Fischer, a recent Stanford PhD in computer science, and Alok Tayi, founder of Vibe Bio, dive into the transformative realm of Decentralized Science (DeSci). They discuss how blockchain can revolutionize traditional scientific practices, making research more transparent and collaborative. Alok shares how Vibe Bio is addressing underfunded diseases, while the group explores the role of DAOs in funding clinical trials, highlighting groundbreaking opportunities for community-driven scientific innovation.

Alok Tayi, co-founder of Vibe Bio, discusses using AI to revolutionize drug development for rare diseases. Topics include personal motivation, complexities in drug development, advantages of DAOs, AI bias, training methods, limitations, and the importance of human intuition in the biopharma industry.